Chinese genomics company BGI has risen to prominence around the world but also has been subject to concerns about its gene sequencing and DNA collection practices. U.S. officials fear BGI's vast collection of global genomics data is not just intended for precision medicine but a strategic asset that could be used for the Chinese military or surveillance, including the development of a biotech-enabled "super soldier.
The U.S. House of Representatives on Monday passed a bill that aims to restrict business with China's WuXi AppTec , BGI and several other biotech companies on national security grounds.
| Textiles, Apparel & Luxury Goods Industry | Consumer Discretionary Sector | Niccolo Rossi di Montelera CEO | AMEX Exchange | 09088U109 CUSIP |
| CA Country | 290 Employees | - Last Dividend | - Last Split | - IPO Date |
Birks Group Inc., with a storied history dating back to 1879, has established itself as a premier designer, developer, manufacturer, and retailer of fine jewelry, timepieces, sterling, and plated silverware, and gifts primarily in the United States and Canada. Operating through two primary segments, Retail and Other, the company showcases a wide array of high-quality merchandise. It has successfully transitioned its brand name from Birks & Mayors Inc. to Birks Group Inc. in September 2013, a move that reflects its expansive portfolio and luxury market positioning. Headquartered in Montreal, Canada, Birks Group continues to cater to the refined tastes of its clientele through its retail stores, branded under Maison Birks, Brinkhaus, Breitling, and Graff and Patek Philippe, as well as Mappin & Webb and Goldsmiths stores, complemented by dynamic e-commerce platforms.